The efficacy and safety of etanercept when used with as-needed adjunctive topical therapy in a randomised, double-blind study in subjects with moderate-to-severe psoriasis (the PRISTINE trial)

Author： Strohal Robert  

Publisher： Informa Healthcare

ISSN： 1471-1753

Source： Journal of Dermatological Treatment, Vol.24, Iss.3, 2013-06, pp. : 169-178

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Double-blind, placebo-controlled study of the efficacy and safety of isotretinoin cream (0.05% w/w and 0.10% w/w) with sunscreens in the treatment of mild to moderate acne vulgaris

By Langner A   Stapor W   Donald AE   Boorman GC  

Journal of Dermatological Treatment, Vol. 11, Iss. 1, 2000-03 ,pp. : 7-14

Informa Healthcare

Access to resources Recommend Favorite

Effect of Aloe vera topical gel combined with tretinoin in treatment of mild and moderate acne vulgaris: a randomized, double-blind, prospective trial

By Hajheydari Zohreh   Saeedi Majid   Morteza-Semnani Katayoun   Soltani Aida  

Journal of Dermatological Treatment, Vol. 25, Iss. 2, 2014-04 ,pp. : 123-129

Informa Healthcare

Access to resources Recommend Favorite

One-year Treatment with 0.1% Tacrolimus Ointment versus a Corticosteroid Regimen in Adults with Moderate to Severe Atopic Dermatitis: A Randomized, Double-blind, Comparative Trial

By Mandelin Johanna   Remitz Anita   Virtanen Hannele   Reitamoskin Sakari  

Acta Dermato-Venereologica, Vol. 90, Iss. 2, 2010-02 ,pp. : 170-174

Medical Journals Limited

Access to resources Recommend Favorite

Morphine Gel 0.3% Does Not Relieve Pain During Topical Photodynamic Therapy: A Randomized, Double-blind, Placebo-controlled Study

By Skiveren Jette   Haedersdal Merete   Philipsen Peter Alshede   Wiegell Stine Regin   Wulf Hans Christian  

Acta Dermato-Venereologica, Vol. 86, Iss. 5, 2006-09 ,pp. : 409-411

Medical Journals Limited

Access to resources Recommend Favorite

Topical TrkA Kinase Inhibitor CT327 is an Effective, Novel Therapy for the Treatment of Pruritus due to Psoriasis: Results from Experimental Studies, and Efficacy and Safety of CT327 in a Phase 2b Clinical Trial in Patients with Psoriasis

By Roblin David   Yosipovitch Gil   Boyce Brent   Robinson John   Sandy James   Mainero Valentina   Wickramasinghe Ro   Anand Uma   Anand Praveen  

Acta Dermato-Venereologica, Vol. 95, Iss. 5, 2015-05 ,pp. : 542-548

Medical Journals Limited

Access to resources Recommend Favorite